Head and Neck Cancer Research: Current Trials

For a full listing of all open and accruing studies, search our Clinical Trials Database

CASE 6316 | 17-069

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

A Phase II Study of the Addition of Pembrolizumab to Postoperative Radiotherapy in Resected High-risk Cutaneous Squamous Cell Cancer of the Head and Neck

RTOG 1008

A randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resecting High-risk Malignant Salivary Gland Tumors

Advertising Policy

ROCHE 1318

A Phase III Multicenter, Randomized, Double-blind Placebo-controlled Study of Atezolizumab as Adjuvant Therapy after Definitive Local Therapy in Patients with High-risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

RTOG 3507 (Opening Soon)

Advertising Policy

A Phase II Study of SBRT Reirradiation with or without Pembrolizumab in Locoregionally Recurrent or Second Primary Inoperable Head and Neck Cancer

 

Search the Head & Neck Cancer section of our Cancer Clinical Trials Database for a full listing of all open and accruing studies.